Compare CTRI & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CTRI | LIVN |
|---|---|---|
| Founded | 1909 | 1987 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 3.5B |
| IPO Year | 2024 | 2015 |
| Metric | CTRI | LIVN |
|---|---|---|
| Price | $30.50 | $73.08 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 7 |
| Target Price | $29.88 | ★ $72.43 |
| AVG Volume (30 Days) | ★ 1.7M | 786.1K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 412.50 | N/A |
| EPS | N/A | ★ 0.40 |
| Revenue | ★ $2,982,781,000.00 | N/A |
| Revenue This Year | $14.62 | $9.79 |
| Revenue Next Year | $8.16 | $6.63 |
| P/E Ratio | ★ N/A | $185.14 |
| Revenue Growth | ★ 13.10 | N/A |
| 52 Week Low | $19.04 | $41.02 |
| 52 Week High | $42.99 | $75.82 |
| Indicator | CTRI | LIVN |
|---|---|---|
| Relative Strength Index (RSI) | 42.58 | 59.98 |
| Support Level | $27.77 | $61.63 |
| Resistance Level | $31.74 | N/A |
| Average True Range (ATR) | 1.32 | 2.37 |
| MACD | -0.34 | 0.24 |
| Stochastic Oscillator | 33.08 | 58.77 |
Centuri Holdings Inc is a pure-play North American utility infrastructure services company that partners with regulated utilities to maintain, upgrade and expand the energy network that powers millions of homes and businesses. Its service offerings consist of the modernization of utility infrastructure through the maintenance, retrofitting and installation of electric and natural gas distribution networks to meet current and future demands while also preparing systems for the transition to clean energy sources. Its reportable segments are: (i) U.S. Gas Utility Services (U.S. Gas); (ii) Canadian Utility Services (Canadian Operations); (iii) Union Electric Utility Services (Union Electric); and (iv) Non-Union Electric Utility Services (Non-Union Electric).
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.